Nancy, I don't have milestones on teh site yet (other tahn links to analyst reports and comments at home.att.net
The site has kept me busy (over 10,000 hits in a week), so I haven't had a chance to update. I also need to call IR to get the latest.
A few upcoming milestones include AHP's IND filing for TSE424 this quarter, decision on LLY option next month, Phase II clinicals this quarter, NDA (topical Panretin for KS) filing this quarter, completion of oral and topical Targretin Phase III for CTCL 3Q, 2 or 3 NDAs for CTCL this year, ABT IND filing for GR modulator, GLX IND this year for LDL modulator, AGN IND filing for anti-retinoid and rexinoid this year, LLY launch of US diabetes trials 2Q or 3Q, LLY IND filing for 2nd generation rexinoid, LGD1550 advancing to Phase II trials, and much more which I'll update when I talk to IR. |
